The PhenoGenetic Project

Trial Purpose and Description

The aim of this project is to determine the role of genetic variation in the diversity of human immune response by testing DNA polymorphisms for association with immunological phenotypes in individuals with no clinical evidence of inflammatory or infectious diseases. In the subject population of this study, immunophenotypes will be characterized from serum and from peripheral blood mononuclear cells (PBMCs). Cytometric, RNA profiling and proteomic platforms will be used in these serological and cellular analyses. This study will genetically dissect human immune gene expression in a cohort of individuals with no clinical evidence of disease, yielding a wealth of data with which to guide the investigation of inflammatory and infectious diseases.

Ages: 18 - 54 years

Gender: Both

Eligibility Criteria

Inclusion Criteria:

Healthy individuals (greater than 18 years of age and less than 55 years of age at enrollment) who are willing to donate blood up to 8 times a year for up to five years or a shorter period of time

Exclusion Criteria:

Subjects who are unable or unwilling to donate blood samples
Individuals with self-reported chronic metabolic diseases (Diabetes Mellitus type II, hypothyroidism, pituitary abnormality), chronic infectious diseases (Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Human T-Lymphotrophic Virus, Tuberculosis), or immune mediated diseases (Ankylosing Spondylitis, Asthma, Diabetes Mellitus type I, Inflammatory Bowel Disease, Multiple Sclerosis, Psoriasis, Rheumatoid Arthritis, Sarcoidosis, Systemic Lupus Erythematosus, Systemic Sclerosis, Thyroiditis), current or prior history of malignancy (solid organ or leukemia/lymphoma), transplant recipients (solid organ or bone marrow) or if currently pregnant.

National Multiple Sclerosis Society

Start Date: 10/12/2010

End Date: 12/31/2025

Last Updated: 06/22/2018

Study HIC#: 1008007275REG

Get Involved

For more information about this study, contact:
Stephanie Eisenbarth

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Stephanie Eisenbarth

Principal Investigator